0.91Open0.91Pre Close0 Volume8 Open Interest17.50Strike Price0.00Turnover195.44%IV46.46%PremiumOct 18, 2024Expiry Date0.00Intrinsic Value100Multiplier19DDays to Expiry0.91Extrinsic Value100Contract SizeAmericanOptions Type0.3099Delta0.0618Gamma13.81Leverage Ratio-0.0518Theta0.0016Rho4.28Eff Leverage0.0103Vega
Perspective Therapeutics Stock Discussion
Larger Image: tradingview.com...
$Perspective Therapeutics (CATX.US)$
$Perspective Therapeutics (CATX.US)$
1:10
$Virgin Galactic (SPCE.US)$ 1:20
$Star Equity (STRR.US)$ 1:5
$Workhorse (WKHS.US)$ 1:20
FDA Selects Perspective Therapeutics To Participate In The CDRP Program To Expedite Chemistry, Manufacturing, and Controls Development Readiness For VMT-α-NET in Neuroendocrine Tumors
The Zhitong Finance App learned that the market value of the Richland, Washington-based company has increased about four times this year to reach US$833 million. Amid the radiopharmaceuticals (also...
No comment yet